Prosecution Insights
Last updated: April 19, 2026

Fennec Pharmaceuticals Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19275772 ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF CRAIG, KAILA ANGELIQUE 1615 Final Rejection Jul 21, 2025
18503027 Anhydrous Sodium Thiosulfate and Formulations Thereof GEMBEH, SHIRLEY V 1615 Non-Final OA Nov 06, 2023
18375162 ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF KWON, JOHN SEUNGJAI 1615 Non-Final OA Sep 29, 2023

Managing Fennec Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month